Overview


According to FutureWise analysis the market for biochips is expected to register a CAGR of 11.4% from 2023-2031.

A biochip is similar to a computer chip, except instead of carrying out several mathematical operations every second, it can carry out biological activities like gene coding and contaminant detection in a matter of seconds. The sensors on a biochip, which might vary depending on the type, are what makes it function. There are biochips available for detecting pH, oxygen, decoding genetic material, and many other things. The most significant part of a biochip is a microarray, a two-dimensional biosensor grid. These sensors are placed on a flat substrate, which may be active or passive. Active substrates help the sensor convert electrical signals into mechanical signals through the use of electronic or electromechanical devices. The majority of the time, microarrays and biochips are employed for DNA analysis. However, other biochips are developed for proteins, antibodies, and chemical compounds. These chips are typically used in tandem with one another to analyze a panel of tests simultaneously using a single sample to create a patient profile.

A bio-microarray device called a "biochip" has undergone substantial research and development to allow for massive genomic, proteomic, and functional genomic investigations. The three primary forms of biochips are microfluidic chips, protein microarrays, and DNA microarrays. Microfluidic and microarray technologies are combined to provide a micro-complete analysis system, often known as a lab-on-a-chip (LOC) system. The size of the biochip has steadily shrunk thanks to advancements in nanotechnology, which has also decreased the cost of manufacture and boosted the capacity for high throughput. This technology has a significant potential to be an essential and potent tool for clinical research, diagnostics, drug development, toxicological investigations, and patient selection for clinical trials because of the advantages of low cost, high throughput, and miniaturization.

FutureWise Market Research has published a report that provides an insightful analysis of biochips market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the biochips market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Affymetrix Inc
  • ROCHE
  • Illumina
  • Life Technologies
  • Beckman Coulter
  • Pacific Biosciences
  • Oxford Nanopore
  • GE Healthcare Life Sciences
  • Abbott Laboratories
  • Medline

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Biochips Market:

In October 2022- To help identify biomarkers and create non-antibiotic therapy options, MicrobioSeq (CD Genomics) introduced the Phage Whole-Genome Sequencing. In order to provide virus/phage sequencing services and support thorough investigations of structural genomics and comparative genomics, CD Genomics makes use of next-generation sequencing and long-read sequencing technologies (primarily Illumina HiSeq, Nanopore, and PacBio SMRT sequencing).

As a result of commercially available devices, biochip applications in genetic diagnostics, drug development, and fundamental research are expected to increase. In addition to genetic applications, which largely examined genetic material for mistakes or sequence variants, the biochip is also being employed in toxicological, protein, and biochemical studies. Chemical weapons are frequently used in biological warfare, and biochips can immediately identify them so that defenses can be put in place. The idea of a dependable, affordable computer chip-like device that can perform a massive number of biological operations is very appealing to drug makers. Because these chips simplify time-consuming laboratory tasks by swapping out large equipment with compact microfluidic assay chemistries, they can provide ultra-sensitive detection techniques at significantly cheaper costs. The widespread use of biochips is anticipated to encourage the market's expansion. Furthermore, biochips are trustworthy instruments for identifying a range of biomarkers with a limited number of samples and have the ability to diagnose and cure the ailment; these chips are in high demand in personalized medicine. Both the use of biochips in personalized medicine and the demand for personalized treatment are on the rise. Over the course of the forecast period, the high demand and quick expansion of this target market are anticipated to increase the prospects for revenue growth for various market players. However, the cost of the finished product is high due to the large initial R&D expenditures and skilled developers needed for the creation of bio-chip technology. It needs automated robotic instruments to handle and scan microscale samples since biochip technology uses microscale probes that are printed on glass surfaces. This technology is quite expensive because it calls for specific equipment and execution techniques. The commercial use of biochips has been put off due to their high cost, which can result in slow growth for this target market.

By Type

  • DNA Chips
    • DNA Chips Market, By Application
      • Gene Expression
      • SNP Genotyping
      • Cancer Diagnosis And Treatment
      • Genomics
      • Drug Discovery
      • Agricultural Biotechnology
      • Other DNA Chip Applications
  • Lab-On-A-Chip
    • Lab-On-A-Chip Market, By Application
      • Clinical Diagnostics
      • Genomics
      • IVD And POC
      • Proteomics
      • Drug Discovery
      • Other Loac Applications Market
  • Protein Chips
    • Protein Chips Market, By Applications
      • Proteomics
      • Expression Profiling
      • Diagnostics
      • High-Throughput Screening
      • Drug Discovery
      • Other Applications
  • Other Arrays
    • Cell Arrays
    • Tissue Arrays

By Fabrication Technology

  • Microarrays
  • Microfluidics

By End User

  • Biotechnology and Pharmaceutical Companies
  • Hospitals and Diagnostics Centers
  • Academic And Research Institutes
  • Other End Users

By Region

  • North America
  • Latin America
  • Europe
  • Asia-Pacific
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022. Due to the growing government attempts to boost R&D through tax incentives, the area is anticipated to maintain its industrial position during the projection period. It is projected that the high concentration of biotechnology companies and academic and research organizations in the area will accelerate future technological developments in biochip applications. R&D tax credits are a budgetary advantage offered by the federal government in the United States to businesses that research to develop, improve, or innovate on goods, services, formulae, or software.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Biochips Market By Type, By Fabrication Technology, By End User and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Biochips Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Biochips Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Biochips Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Biochips Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Biochips Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. DNA Chips
         1.1 . DNA Chips Market, By Application
          1.1.1 . Gene Expression
          1.1.2 . SNP Genotyping
          1.1.3 . Cancer Diagnosis And Treatment
          1.1.4 . Genomics
          1.1.5 . Drug Discovery
          1.1.6 . Agricultural Biotechnology
          1.1.7 . Other DNA Chip Applications
        2. Lab-On-A-Chip
         2.1 . Lab-On-A-Chip Market, By Application
          2.1.1 . Clinical Diagnostics
          2.1.2 . Genomics
          2.1.3 . IVD And POC
          2.1.4 . Proteomics
          2.1.5 . Drug Discovery
          2.1.6 . Other Loac Applications Market
        3. Protein Chips
         3.1 . Protein Chips Market, By Applications
          3.1.1 . Proteomics
          3.1.2 . Expression Profiling
          3.1.3 . Diagnostics
          3.1.4 . High-Throughput Screening
          3.1.5 . Drug Discovery
          3.1.6 . Other Applications
        4. Other Arrays
         4.1 . Cell Arrays
         4.2 . Tissue Arrays

  • 8.   Biochips Market, By Fabrication Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Microarrays
        2. Microfluidics

  • 9.   Biochips Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Biotechnology and Pharmaceutical Companies
        2. Hospitals and Diagnostics Centers
        3. Academic And Research Institutes
        4. Other End Users

  • 10.   North America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Regional Market Trends
        3. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         3.1. Brazil
         3.2. Venezuela
         3.3. Argentina
         3.4. Rest of Latin America
        4. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Switzerland
         2.9. Rest of Western Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. Singapore
         2.4. India
         2.5. Australia and New Zealand
         2.6. ASEAN
         2.7. South Korea
         2.8. Taiwan
         2.9. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
    •   1. Affymetrix Inc
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. ROCHE
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Illumina
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Life Technologies
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Beckman Coulter
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Pacific Biosciences
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Oxford Nanopore
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. GE Healthcare Life Sciences
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Abbott Laboratories
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Medline
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients